Recently, U.S. President Donald Trump sent out a letter to over a dozen major pharmaceutical companies demanding they lower the cost of drugs in the United States and raise prices in other countries, including Canada. Michael Fougere, CEO for the Pharmacy Association of Saskatchewan, joins Tamara Cherry to discuss what this could mean for Canadians if the companies follow through with Trump's demands.